Danimer Scientific

Danimer Scientific, Inc. operates as a next generation bioplastics company. It focuses on the development and production of biodegradable materials. The firm sells its products under the brand name Nodax. Its applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles. The company was founded on January 13, 2014 and is headquartered in Bainbridge, GA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Danimer Scientific secures $130M loan, eyes profitability amid challenges

Danimer Scientific's Q4 2022 earnings call highlighted revenue figures, adjusted EBITDA losses, and strategic plans for profitability in 2023.
The company's strengths lie in its strong executive team, sustainability focus, key partnerships, and successful financing initiatives.
Challenges include cost estimates for projects, achieving profitability, managing off-take agreements, and balancing financial needs with shareholder interests.
Opportunities exist in the growing demand for sustainable materials, global brand partnerships, revenue growth, and market disruption for Danimer.

Danimer Scientific reports mixed Q1 results, eyes growth opportunities

Danimer Scientific's Q1 2023 performance showed mixed results with revenue decline but improved EBITDA loss and increased liquidity. The company's strengths lie in cost control, new commercial opportunities, and partnerships. Challenges include fluctuating canola prices and interest expenses, while opportunities include growth in PHA-based materials and positive business momentum.

Danimer Scientific reports revenue growth amidst challenges, eyes sustainability opportunities

Danimer Scientific's Q2 performance reflected revenue growth driven by PHA-based resin sales, despite facing a gross loss due to higher expenses.
The company's emphasis on innovation, sustainability, and government support positions them well in the market, despite financial challenges and geopolitical risks.
Opportunities in new product development, market expansion, and operational growth present avenues for Danimer to enhance its competitive position and drive future success.

Danimer Scientific reports Q3 revenue growth amidst sustainability focus

Danimer Scientific's Q3 performance showed revenue growth driven by PHA-based resin sales, despite challenges in managing costs.
The company's strategic strengths lie in securing significant awards and its commitment to sustainability initiatives.
While facing financial challenges, Danimer has opportunities for growth through upcoming funding and market demand for eco-friendly solutions.

Danimer Scientific reports Q4 losses but highlights industry successes

Danimer Scientific faces challenges with delays in commercial launches and financial losses in Q4 2023. However, the company's strengths lie in its successes in biodegradable plastics, partnerships with key players, and progress in plant completion and market expansion. Opportunities for growth exist in product development, partnerships, and market prospects.

Danimer Scientific reports robust Q1 performance amidst revenue challenges

Danimer Scientific's Q1 performance reflects strong growth in PHA revenues and promising commercial partnerships.
While facing short-term challenges from revenue headwinds, the company's operational improvements and financial support position it well for future opportunities.
Managing liquidity and focusing on customer demand forecasts will be key in navigating the path towards profitability and sustainable growth.

Danimer Scientific reports Q3 revenue challenges but strengthens sustainability focus

Danimer Scientific's Q3 performance reflects a mixed financial picture with revenue challenges but improved EBITDA losses and strong liquidity focus.
The company's strengths lie in its sustainability focus, commercial partnerships, and leadership's confidence in future growth prospects.
While facing debt and revenue challenges, Danimer Scientific has opportunities to enhance financial flexibility, capitalize on market demand for sustainable solutions, and expand its commercial reach.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SAN FRANCISCO, May 18, 2021 /PRNewswire/ -- Hagens Berman urges Danimer Scientific, Inc. (NYSE: DNMR) investors with significant losses to submit your losses now.  Class Period: Dec. 30, 2020 - Mar. 19, 2021 Lead Plaintiff Deadline: July 13, 2021 Visit: www.hbsslaw.com/investor-fraud/DNMR  Contact An Attorney Now: DNMR@hbsslaw.com                                              844-916-0895 Danimer Scientific, Inc. (NYSE: DNMR) Securities Fraud Action: The complaint centers on Danimer's alleged misrepresentations and omissions concerning its claims to be a leading producer of polyhydroxyalkanoate ("PHA") – a biodegradeable alternative to petrochemical-based plastics, which the company sells under its proprietary Nodax® brand for usage in water bottles, straws, and food containers.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Danimer Scientific (DNMR) Investors with Losses To Contact Its Attorneys Now, Securities Fraud Case Filed

Investors need to pay close attention to Danimer (DNMR) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Danimer (DNMR) Stock?

Danimer Scientific, Inc. (DNMR) CEO Steve Croskrey on Q1 2021 Results - Earnings Call Transcript

NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 13, 2021 to file lead plaintiff applications in a securities class action lawsuit against Danimer Scientific, Inc. (NYSE: DNMR), if they purchased the Company's securities between December 30, 2020 and March 19, 2021, inclusive (the “Class Period”). This action is pending in the United States District Court for t

DANIMER SCIENTIFIC SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Danimer Scientific, Inc. - DNMR

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Danimer Scientific To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 17, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Danimer Scientific Inc. ("Danimer Scientific" or the "Company") (NYSE: DNMR).If you suffered losses exceeding $50,000 investing in Danimer Scientific stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for...

Danimer Scientific Investor Alert

LOS ANGELES--(BUSINESS WIRE)---- $DNMR #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Danimer Scientific Inc. (“Danimer” or the “Company”) (NYSE: DNMR) securities between December 30, 2020 and March 19, 2021, inclusive (the “Class Period”). Danimer investors have until July 13, 2021 to file a lead plaintiff motion. If you suffered a loss on your Danime

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Danimer Scientific Inc. (DNMR) Investors

SAN DIEGO--(BUSINESS WIRE)-- #DNMRstock--The suit alleges defendants issued false statements concerning Danimer business and prospects, resulting in its stock trading at inflated prices.

Notice of Lead Plaintiff Deadline for Shareholders in the Danimer Scientific, Inc. Class Action Lawsuit

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today its financial results for the quarter ended March 31, 2021. “Danimer Scientific remains at the forefront of the bioplastics industry as the premier supplier of PHA biopolymers to blue-chip multinational corporations that are committed to reducing single-use plastic

Danimer Scientific, a Next Generation Bioplastics Company, Announces First Quarter 2021 Results

BENSALEM, Pa.--(BUSINESS WIRE)---- $DNMR #CLASSACTION--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Danimer Scientific Inc. (“Danimer” or the “Company”) (NYSE: DNMR) securities between December 30, 2020 and March 19, 2021, inclusive (the “Class Period”). Danimer investors have until July 13, 2021 to file a lead plaintiff motion. Investors suffering losses on their Danimer investments are encouraged to contact the Law Offices of Howard G. Smit

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Danimer Scientific Inc. (DNMR) Investors

NEW YORK--(BUSINESS WIRE)-- #Class--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, announces that a class action lawsuit has been filed in the United States District Court for the Eastern District of New York on behalf of investors that purchased Danimer Scientific, Inc. (NYSE: DNMR) securities between December 30, 2020 and March 19, 2021, inclusive (the “Class Period”). Investors have until July 13, 2021 to apply to the Court to be appointed as lead plaintiff in t

DANIMER SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Danimer Scientific, Inc. and Encourages Investors to Contact the Firm

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Danimer Scientific, Inc. (NYSE: DNMR) between December 30, 2020 and March 19, 2021, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 13, 2021. SO WHAT: If you purchased Danimer Scientific securities during the C

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Danimer Scientific, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – DNMR

NEW YORK, May 14, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Danimer Scientific, Inc. ("Danimer" or the "Company") (NYSE: DNMR) and certain of its officers and directors. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 21-cv-02708, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Danimer securities between December 30, 2020 and March 19, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Pomerantz Law Firm Announces the Filing of a Class Action Against Danimer Scientific, Inc. and Certain Officers and Directors - DNMR

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific (NYSE:DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that it will redeem all of its outstanding warrants (the “Public Warrants”) to purchase shares of the its common stock, $0.0001 par value per share (the “Common Stock”), that were issued under the Warrant Agreement, dated as of May 5, 2020 (the “Warrant Agreement”), by an

Danimer Scientific Announces Redemption of Public Warrants

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific (NYSE: DNMR), a leading developer and manufacturer of biodegradable materials, today announced it has received a Small Business Innovation Research (SBIR) grant to research pennycress oil as a potential feedstock material for producing polyhydroxyalkanoate (PHA), a biodegradable, eco-friendly alternative to traditional plastic. Danimer Scientific will partner with the University of Minnesota's Forever Green Initiative starting in July 2021 to

Danimer Scientific Receives Innovation Research Grant to Support Biodegradable Plastic Solutions

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today provided additional information to help investors better understand its business in light of unfortunate misconceptions, falsehoods and speculation that have been circulating about the Company. Stephen E. Croskrey, Chief Executive Officer of Danimer Scientific, said, “As a result

Danimer Scientific Provides Additional Information for Investors

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced a response to the public statement issued by the staff of the Securities and Exchange Commission on April 12, 2021 (the “Staff Statement”) regarding accounting and reporting considerations for warrants issued by Special Purpose Acquisition Companies (“SPACs”). Similar to

Danimer Scientific Responds to SEC Staff Statement Regarding Accounting Treatment of Warrants

BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2021 financial results after the market closes on Monday, May 17, 2021. A webcast and conference call will be held that same day at 5:00 p.m. Eastern Time to review the Company's first quarter results, discuss recent events

Danimer Scientific Announces Date for First Quarter 2021 Results

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Danimer Scientific To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - May 1, 2021) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Danimer Scientific Inc. ("Danimer Scientific" or the "Company") (NYSE: DNMR).If you suffered losses exceeding $50,000 investing in Danimer Scientific stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for...

Danimer Scientific Shareholder Alert

Boston, Massachusetts--(Newsfile Corp. - April 28, 2021) - Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, reminds investors that it is investigating Danimer Scientific, Inc. (NYSE: DNMR) for potential violations of the federal securities laws. Danimer produces a biodegradable plastic alternative sold under the brand name Nodax. On March 20, 2021, the Wall Street Journal published an article entitled "Plastic Straws That Quickly Biodegrade in the Ocean? Not Quite, Scientists Say." The WSJ...

SHAREHOLDER ALERT: Danimer Scientific, Inc. Investigated for Possible Securities Laws Violations by Block & Leviton LLP; Investors Should Contact the Firm

An overview of Danimer Scientific and its market opportunity in bio-plastics. The company is on track to significantly expand production supported by strong demand for environmentally sustainable product solutions.

Danimer Scientific Inc.: 'Bio-Plastics' Growth Opportunity

NEW YORK, April 23, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Danimer Scientific Inc. ("Danimer" or the "Company") (NYSE: DNMR). Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Danimer Scientific Inc. - DNMR

NEW YORK--(BUSINESS WIRE)-- #DanimerScientific--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Danimer Scientific, Inc. (NYSE: DNMR) on behalf of Danimer stockholders. Our investigation concerns whether Danimer has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On March 20, 2021, the Wall Street Journal published an article entitled “Plastic Straws That

DANIMER SCIENTIFIC ALERT: Bragar Eagel & Squire, P.C. is Investigating Danimer Scientific, Inc. on Behalf of Danimer Stockholders and Encourages Investors to Contact the Firm

Los Angeles, California--(Newsfile Corp. - April 1, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Danimer Scientific, Inc. ("Danimer" or "the Company") (NYSE: DNMR) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. The Wall Street Journal published an article on March 20, 2021,...

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Danimer Scientific, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

The stock price of Danimer Scientific, Inc. (NYSE: DNMR) increased by over 15% during intraday trading. This is why it happened.

DNMR Stock Price Increased Over 15% Intraday: Why It Happened

LOS ANGELES--(BUSINESS WIRE)---- $DNMR #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”), a national investor rights law firm, continues its investigation on behalf of Danimer Scientific Inc. (“Danimer” or the “Company”) (NYSE: DNMR) investors concerning the Company and its officers' possible violations of the federal securities laws. If you suffered a loss on your Danimer investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit

News for Danimer Scientific Stock (DNMR)